The Clock Is Ticking to Buy This Game-Changing Stock at a Discount

Novocure (NASDAQ: NVCR) stands out as a great example and is attractively valued right now. TTFields use electric fields that are tuned to specific frequencies to interfere with the division of cancer cells. Novocure has already demonstrated that TTFields work well in treating glioblastoma multiforme (GBM), an aggressive form of brain cancer.